|
LIG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.257600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.561700E-02 |
| Normal-vs-Stage2 |
2.947000E-01 |
| Normal-vs-Stage3 |
2.308800E-01 |
| Normal-vs-Stage4 |
4.488400E-01 |
| Stage1-vs-Stage2 |
4.418400E-03 |
| Stage1-vs-Stage3 |
4.477600E-01 |
| Stage1-vs-Stage4 |
3.862200E-01 |
| Stage2-vs-Stage3 |
5.228300E-02 |
| Stage2-vs-Stage4 |
1.213840E-01 |
| Stage3-vs-Stage4 |
8.120200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.948000E-02 |
| Normal-vs-AfricanAmerican |
8.858000E-02 |
| Normal-vs-Asian |
2.016700E-03 |
| Caucasian-vs-AfricanAmerican |
3.601600E-01 |
| Caucasian-vs-Asian |
7.247600E-02 |
| AfricanAmerican-vs-Asian |
9.269400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.233440E-01 |
| Normal-vs-Female |
1.209620E-01 |
| Male-vs-Female |
7.289000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.058200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.231400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.202200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.260000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.150780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.678000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.035400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.763000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.473200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.013200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.662020E-03 |
| Classical-VS-Follicular |
2.12110000008536E-07 |
| Classical-VS-Other |
9.402400E-01 |
| Classical-VS-Normal |
9.803100E-04 |
| Tall-VS-Follicular |
6.358200E-02 |
| Tall-VS-Other |
4.488600E-01 |
| Tall-VS-Normal |
9.309600E-01 |
| Follicular-VS-Other |
1.195020E-01 |
| Follicular-VS-Normal |
4.524300E-02 |
| Other-VS-Normal |
4.631000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.959800E-01 |
| Normal-vs-N1 |
1.243600E-01 |
| N0-vs-N1 |
4.680600E-01 |
|
|
